Viewing Study NCT00471367

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:32 AM
Ignite Modification Date: 2026-01-04 @ 1:27 AM
Study NCT ID: NCT00471367
Status: TERMINATED
Last Update Posted: 2009-09-24
First Post: 2007-05-07
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD4877
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma View
None NHL View
None Non-Hodgkin Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Phase I View
None AZD4877 View
None Lymphoma View
None B-cell non-Hodgkin lymphoma View